• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖的突尼斯成年人肌少症的患病率及其危险因素。

Sarcopenia prevalence and risk factors in obese Tunisian adults.

机构信息

University of Tunis El Manar, Faculty of Medicine of Tunis, 1007, Department A, National Institute of Nutrition and Food Technology of Tunis, Tunisia.

University of Tunis El Manar, Higher School of Health Sciences and Techniques of Tunis, 1007, Tunisia.

出版信息

Tunis Med. 2024 Aug 5;102(8):465-471. doi: 10.62438/tunismed.v102i8.4965.

DOI:10.62438/tunismed.v102i8.4965
PMID:39129573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11390009/
Abstract

INTRODUCTION

Sarcopenia is a clinical condition defined as low skeletal muscle mass and function. It has been identified and described as a geriatric syndrome, but it may arise in individuals with obesity at any age.

AIM

screen for sarcopenia in obese adults and identify the nutritional, clinical and biological risk factors associated with the development of sarcopenic obesity (SO+).

METHODS

Descriptive cross-sectional study, including 53 obese patients. Screening for sarcopenia has been established according to pathological thresholds proposed by the European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO).

RESULTS

Mean age was 44.34±13.51 years. Prevalence of Sarcopenia was 7.5% (SO+). The average intakes of calorie, lipids and saturated fatty acids were higher in SO+. A statistically significant relationship was found between low skeletal muscle mass (SMM/W) and the average intake of vitamin PP (p=0.014) and vitamin B9 (p=0.009). Mean BMI (45.86 kg/m² for SO+ versus 39.29 kg/m² for SO-; p=0.03) and mean visceral fat (16.55 l for SO+, versus 10.93 l for SO-; p=0.043) were significantly higher in SO+. A statistically significant relationship was found between insulin resistance and low (SMM/W), as attested by mean insulinemia (28.81 µIU/mL for low SMM/W, versus 14.48 µIU/mL for normal SMM/W; p=0.004) and HOMA index (7.94 for low SMM/W, versus 3.49 for normal SMM/W; p=0.002), which were higher in cases of low (SMM/W).

CONCLUSION

We recommend promoting a balanced, low-energy-density diet to improve insulin sensibility and thus reduce the risk of sarcopenia. Regular physical activity is also strongly recommended.

摘要

简介

肌少症是一种以骨骼肌量和功能低下为特征的临床病症。肌少症已被确定为一种老年综合征,但它也可能在任何年龄的肥胖个体中发生。

目的

筛查肥胖成年人的肌少症,并确定与肌少症性肥胖(SO+)发生相关的营养、临床和生物学危险因素。

方法

这是一项描述性的横断面研究,共纳入了 53 名肥胖患者。肌少症的筛查是根据欧洲临床营养与代谢学会(ESPEN)和欧洲肥胖研究协会(EASO)提出的病理阈值来确定的。

结果

患者的平均年龄为 44.34±13.51 岁。肌少症的患病率为 7.5%(SO+)。SO+组的热量、脂类和饱和脂肪酸的平均摄入量较高。低骨骼肌质量(SMM/W)与烟酸(PP)和维生素 B9 的平均摄入量呈显著负相关(p=0.014 和 p=0.009)。SO+组的平均 BMI(45.86 kg/m²)和平均内脏脂肪(16.55 l)明显高于 SO-组(分别为 39.29 kg/m²和 10.93 l,p=0.03 和 p=0.043)。胰岛素抵抗与低 SMM/W 呈显著正相关,表现为低 SMM/W 时的平均胰岛素血症(28.81 µIU/mL,正常 SMM/W 时为 14.48 µIU/mL;p=0.004)和 HOMA 指数(低 SMM/W 时为 7.94,正常 SMM/W 时为 3.49;p=0.002)均较高。

结论

我们建议促进均衡、低能量密度的饮食,以改善胰岛素敏感性,从而降低肌少症的风险。还强烈建议定期进行身体活动。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/db6af594dc06/capture5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/4217d9810774/capture1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/ef8d28ea89a4/capture2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/096b66b82428/capture3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/eb246d8a9b24/capture4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/db6af594dc06/capture5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/4217d9810774/capture1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/ef8d28ea89a4/capture2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/096b66b82428/capture3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/eb246d8a9b24/capture4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fdff/11390009/db6af594dc06/capture5.jpg

相似文献

1
Sarcopenia prevalence and risk factors in obese Tunisian adults.肥胖的突尼斯成年人肌少症的患病率及其危险因素。
Tunis Med. 2024 Aug 5;102(8):465-471. doi: 10.62438/tunismed.v102i8.4965.
2
Sarcopenic obesity by the ESPEN/EASO criteria for predicting mortality in advanced non-small cell lung cancer.根据 ESPEN/EASO 标准,肌少症性肥胖可预测晚期非小细胞肺癌患者的死亡率。
Clin Nutr. 2023 Jun;42(6):817-824. doi: 10.1016/j.clnu.2023.04.010. Epub 2023 Apr 13.
3
Sarcopenic obesity in nursing home residents: a multi-center study on diagnostic methods and their association with instrumental activities of daily living.养老院居民的肌肉减少性肥胖:一种多中心研究诊断方法及其与工具性日常生活活动的关系。
BMC Geriatr. 2024 May 21;24(1):446. doi: 10.1186/s12877-024-04955-w.
4
Analysis of sarcopenic obesity prevalence and diagnostic agreement according to the 2022 ESPEN and EASO Consensus in hospitalized older adults with severe obesity.分析 2022 年 ESPEN 和 EASO 共识中关于严重肥胖住院老年患者的肌少症性肥胖患病率和诊断一致性。
Front Endocrinol (Lausanne). 2024 Jun 20;15:1366229. doi: 10.3389/fendo.2024.1366229. eCollection 2024.
5
Sarcopenic obesity and falls in older adults: A validation study of ESPEN/EASO criteria and modifications in Western China communities.肌少症性肥胖与老年人跌倒:ESPEN/EASO 标准及其在中国西部社区修正版的验证研究。
Arch Gerontol Geriatr. 2024 Dec;127:105557. doi: 10.1016/j.archger.2024.105557. Epub 2024 Jul 1.
6
Assessment of sarcopenic obesity as a predictor of pneumonia in patients with stable schizophrenia-A prospective study.评估肌少症性肥胖作为稳定期精神分裂症患者肺炎的预测因子:一项前瞻性研究。
Clin Nutr ESPEN. 2024 Apr;60:343-347. doi: 10.1016/j.clnesp.2024.02.028. Epub 2024 Feb 27.
7
Sarcopenia prevalence and functional outcomes in older men with obesity: Comparing the use of the EWGSOP2 sarcopenia versus ESPEN-EASO sarcopenic obesity consensus definitions.肥胖老年男性的肌肉减少症患病率和功能结局:比较使用 EWGSOP2 肌肉减少症与 ESPEN-EASO 肌肉减少性肥胖共识定义。
Clin Nutr. 2023 Sep;42(9):1610-1618. doi: 10.1016/j.clnu.2023.07.014. Epub 2023 Jul 17.
8
Neck circumference as a potential indicator of pre-sarcopenic obesity in a cohort of community-based individuals.颈围可作为社区人群中肌少型肥胖前期的潜在指标。
Clin Nutr. 2024 Jan;43(1):11-17. doi: 10.1016/j.clnu.2023.11.006. Epub 2023 Nov 15.
9
Prevalence of sarcopenic obesity based on newly proposed diagnostic criteria and functional outcomes in older adults undergoing rehabilitation.基于新提出的诊断标准及功能结局对老年康复患者进行的肌少症性肥胖患病率研究。
Mech Ageing Dev. 2022 Dec;208:111728. doi: 10.1016/j.mad.2022.111728. Epub 2022 Sep 6.
10
Sarcopenic obesity diagnosis by different criteria mid-to long-term post-bariatric surgery.肥胖型肌少症的不同诊断标准在减重手术后的中远期评估。
Clin Nutr. 2022 Sep;41(9):1932-1941. doi: 10.1016/j.clnu.2022.07.006. Epub 2022 Jul 10.

本文引用的文献

1
Sarcopenic Obesity and Cardiometabolic Health and Mortality in Older Adults: a Growing Health Concern in an Ageing Population.肌少症性肥胖与老年人的心脏代谢健康和死亡率:老龄化人口中日益严重的健康问题。
Curr Diab Rep. 2023 Nov;23(11):307-314. doi: 10.1007/s11892-023-01522-2. Epub 2023 Aug 11.
2
Sarcopenic obesity in free-living older adults detected by the ESPEN-EASO consensus diagnostic algorithm: Validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile.采用 ESPEN-EASO 共识诊断算法检测的社区居住老年人的肌肉减少性肥胖症:在意大利队列中的验证及胰岛素抵抗和改变的血浆 ghrelin 谱的预测价值。
Metabolism. 2023 Aug;145:155595. doi: 10.1016/j.metabol.2023.155595. Epub 2023 May 26.
3
Compartmentalizing risk with sarcopenic obesity.
Liver Transpl. 2023 May 1;29(5):463-464. doi: 10.1097/LVT.0000000000000061. Epub 2023 Jan 3.
4
Gender-Specific Prevalence and Risk Factors of Sarcopenic Obesity in the Korean Elderly Population: A Nationwide Cross-Sectional Study.性别特异性的韩国老年人群体肌少型肥胖患病率及相关因素:一项全国性横断面研究。
Int J Environ Res Public Health. 2023 Jan 9;20(2):1140. doi: 10.3390/ijerph20021140.
5
Prevalence and risk factors of sarcopenia without obesity and sarcopenic obesity among Chinese community older people in suburban area of Shanghai: A cross-sectional study.上海郊区社区老年人中无肥胖型肌肉减少症和肌肉减少性肥胖症的患病率及危险因素:一项横断面研究。
Front Aging Neurosci. 2022 Dec 20;14:1034542. doi: 10.3389/fnagi.2022.1034542. eCollection 2022.
6
The Risk of Sarcopenia among Adults with Normal-Weight Obesity in a Nutritional Management Setting.营养管理环境中正常体重肥胖成年人发生肌肉减少症的风险。
Nutrients. 2022 Dec 13;14(24):5295. doi: 10.3390/nu14245295.
7
Deciphering the "obesity paradox" in the elderly: A systematic review and meta-analysis of sarcopenic obesity.解读老年人中的“肥胖悖论”:对肌少症性肥胖的系统评价和荟萃分析。
Obes Rev. 2023 Feb;24(2):e13534. doi: 10.1111/obr.13534. Epub 2022 Nov 28.
8
Food insecurity as a risk factor of sarcopenic obesity in older adults.粮食不安全作为老年人肌少性肥胖的一个风险因素。
Front Nutr. 2022 Oct 20;9:1040089. doi: 10.3389/fnut.2022.1040089. eCollection 2022.
9
Association of Dietary Factors With Grip Strength, Body Fat, and Prevalence of Sarcopenic Obesity in Rural Korean Elderly With Cardiometabolic Multimorbidity.韩国农村患有心脏代谢多重疾病的老年人中饮食因素与握力、体脂及肌少症肥胖患病率的关联
Front Nutr. 2022 Jul 14;9:910481. doi: 10.3389/fnut.2022.910481. eCollection 2022.
10
Pilot study for the development of a screening questionnaire to detect sarcopenic obesity.用于开发一种筛查问卷以检测肌少症性肥胖的初步研究。
Int J Obes (Lond). 2022 Jul;46(7):1328-1331. doi: 10.1038/s41366-022-01118-y. Epub 2022 Apr 9.